Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > With some here suspecting Apotex may be Labs global

<< Previous

Bullboard Posts

Next >>

Post by mdjbrownon Oct 06, 2023 12:31pm

161 Views

Post# 35673389

With some here suspecting Apotex may be Labs global

secret partner who filed an ANDA in late September 2022, and with the recent FDA inspection of the Barrie facility, and the recent generic Epidiloex lawsuit launched by GW against Apotex, it makes sense that someone with CBD credentials and capabilities had to fill CannTrusts spot after they crashed and burned. A generic version of Epidiolex will be a goldmine for the first Pharmaco to ring that bell.

Looks like Apotex was already looking at CBD possibilities back in 2018

https://www.newswire.ca/news-releases/canntrust-and-apotex-accelerate-partnership-to-fuel-global-expansion-in-medical-cannabis-market-690339301.html

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features